ROIV 8-K 2026-09-08

Roivant Sciences Ltd. (ROIV) 8-K dated 2026-09-08 — accession 0001140361-26-035859. This URL is the filing, not the ROIV hub.

Roivant Sciences Ltd. (ROIV) is a biotechnology company listed on US.

Roivant Sciences Ltd. filed a 8-K on 2026-09-08. Accession 0001140361-26-035859.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.

Not investment advice. The ROIV SEC hub lists recent forms. The stock page is the research view.